PITX3 Gene Anterior Segment Mesenchymal Dysgenesis Genetic Test
At DNA Labs UAE, we offer the PITX3 Gene Anterior Segment Mesenchymal Dysgenesis Genetic Test for individuals who may be affected by this condition. This test is designed to provide valuable information about the PITX3 gene and its role in the development of the eye.
Test Components
The PITX3 Gene Anterior Segment Mesenchymal Dysgenesis Genetic Test includes:
- NGS Technology
- Ophthalmology Disorders Test Type
- Genetics Test Department
Price
The cost of the PITX3 Gene Anterior Segment Mesenchymal Dysgenesis Genetic Test is 4400.0 AED.
Sample Condition
We accept the following sample conditions for this test:
- Blood
- Extracted DNA
- One drop of Blood on FTA Card
Report Delivery
You can expect to receive your test report within 3 to 4 weeks after sample submission.
Method
The PITX3 Gene Anterior Segment Mesenchymal Dysgenesis Genetic Test utilizes NGS (next-generation sequencing) technology for accurate and efficient sequencing of large amounts of DNA.
Test Type
This test specifically focuses on Ophthalmology Disorders, particularly the anterior segment mesenchymal dysgenesis (ASMD) caused by mutations in the PITX3 gene.
Doctor
This test is recommended to be conducted under the supervision of an Ophthalmologist.
Pre Test Information
Prior to the test, it is essential to provide the clinical history of the patient who is undergoing the PITX3 Gene Anterior Segment Mesenchymal Dysgenesis NGS Genetic DNA Test. Additionally, a genetic counseling session will be conducted to draw a pedigree chart of family members affected by this condition.
Test Details
The PITX3 gene is responsible for producing a protein that plays a crucial role in eye development. Mutations in this gene can lead to anterior segment mesenchymal dysgenesis (ASMD), a rare condition that affects the front part of the eye. ASMD can cause various eye problems, including glaucoma, cataracts, and corneal clouding.
NGS genetic testing is a powerful tool that enables the identification of mutations in the PITX3 gene, aiding in the diagnosis of ASMD. It can also assist in determining the most suitable treatment options for affected individuals and identifying family members who may be at risk of developing the condition.
| Test Name | PITX3 Gene Anterior segment mesenchymal dysgenesis Genetic Test |
|---|---|
| Components | |
| Price | 4400.0 AED |
| Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
| Report Delivery | 3 to 4 Weeks |
| Method | NGS Technology |
| Test type | Ophthalmology Disorders |
| Doctor | Ophthalmologist |
| Test Department: | Genetics |
| Pre Test Information | Clinical History of Patient who is going for PITX3 Gene Anterior segment mesenchymal dysgenesis NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with PITX3 Gene Anterior segment mesenchymal dysgenesis NGS Genetic DNA Test gene PITX3 |
| Test Details | The PITX3 gene is a gene that provides instructions for making a protein that is important for the development of the eye. Mutations in this gene can cause a condition called anterior segment mesenchymal dysgenesis (ASMD), which affects the development of the front part of the eye. NGS (next-generation sequencing) genetic testing is a type of genetic testing that can sequence large amounts of DNA quickly and accurately. This type of testing can be used to identify mutations in the PITX3 gene that may be causing ASMD. ASMD is a rare condition that can cause a range of eye problems, including glaucoma, cataracts, and corneal clouding. Genetic testing can be useful in diagnosing ASMD and determining the best course of treatment for affected individuals. It can also be used to identify family members who may be at risk of developing the condition. |
